Delivery Order SPE2DB24D1205-SPE2DB25FDARU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract value of $4,620.93. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by September 25, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a $4,620.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a non-set-aside competitive award with an ultimate completion date of September 11, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $13,862.79. This non-set-aside competitive award, with an ultimate completion date of August 18, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) with a completion date of September 19, 2025. This firm fixed-price delivery order, issued on August 28, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing DLA Troop Support...
- The Defense Logistics Agency awarded a $13.86K delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed price contract with no set-aside designation, scheduled for completion by September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 15, 2025, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) on May 30, 2025, with a completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) under a firm fixed-price contract with a ceiling value of $4,620.93. The award was made on September 15, 2025, with an ultimate completion date of October 6, 2025. This non-set-aside award represents a competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $4,620.93, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award reflects AmerisourceBergen's capability to deliver pharmaceutical products to support federal medical procurement needs. The contract is executed out of the vendor's corporate office location in Conshohocken,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDARUDelivery Order
The Defense Logistics Agency awarded a $4,620.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This non-set-aside delivery order, with an ultimate completion date of October 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated consistent capability to meet DLA requirements through competitively awarded contracts covering a broad spectrum of pharmaceutical products and medical supplies. The company's DLA Troop Support Medical IDC enables it to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Zeposia, a neurological treatment medication, reflects the company's ongoing role as a key supplier within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/19/25 |